Perinatal Outcomes and Uptake of RSV Vaccine During Pregnancy

BMJ Open, 2025

Dr Mohammad Sharif Razai
NIHR Clinical Lecturer in Primary Care

This is the first UK study to report uptake of the newly introduced maternal respiratory syncytial virus (RSV) vaccine and its association with sociodemographic and perinatal outcomes. Led by researchers from University of Cambridge and City St George’s, University of London, the study found major disparities in uptake by socioeconomic status and ethnicity. RSV vaccination rates were higher among older, White and less deprived women, and lower among those from ethnic minority and more deprived backgrounds. There was no evidence of increased risk of preterm birth or other adverse perinatal outcomes among vaccinated women. These findings highlight encouraging early trends whilst underscoring the need to promote equitable maternal RSV vaccination across diverse populations.

Read the open-access article here: Perinatal outcomes and uptake of RSV vaccine during pregnancy in South London: a cross-sectional study | BMJ Open

LinkedIn post: New Publication in BMJ Open